MedTrace Logo

A Study Evaluating Quality of Life Parameters Following Use of Emergen-C

NCT06654089 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 299

Last updated 2026-04-07

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine how Emergen-C use can improve quality of life (QoL) in a real-world setting to help consumers and healthcare professionals understand the benefits of taking Emergen-C on a routine or daily basis.

Conditions

  • Dietary Supplements

Interventions

DIETARY_SUPPLEMENT

Emergen-C Core Super Orange Powder

A dietary supplement powder containing vitamin C, zinc, vitamin B6, vitamin B12, folate, and manganese.

DIETARY_SUPPLEMENT

Placebo

To ensure proper blinding, the placebo was formulated to be indistinguishable from Emergen-C in taste, appearance, and other sensory characteristics. The placebo therefore contained fructose, and the electrolytes potassium, magnesium, calcium, and sodium.

Sponsors & Collaborators

  • HALEON

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-30
Primary Completion
2025-02-24
Completion
2025-02-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06654089 on ClinicalTrials.gov